company background image
BDXB

Becton DickinsonNYSE:BDXB Stock Report

Last Price

US$54.69

Market Cap

US$75.2b

7D

0%

1Y

-3.3%

Updated

20 Jan, 2022

Data

Company Financials +
BDXB fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health4/6
Dividends4/6

BDXB Stock Overview

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

Becton Dickinson Competitors

Medtronic

NYSE:MDT

US$144.9b

Stryker

NYSE:SYK

US$97.4b

Hologic

NasdaqGS:HOLX

US$17.7b

Penumbra

NYSE:PEN

US$8.2b

Price History & Performance

Summary of all time highs, changes and price drops for Becton Dickinson
Historical stock prices
Current Share PriceUS$54.69
52 Week HighUS$60.00
52 Week LowUS$50.21
Beta0.72
1 Month Change4.23%
3 Month Change2.82%
1 Year Change-3.32%
3 Year Changen/a
5 Year Changen/a
Change since IPO8.30%

Recent News & Updates

Shareholder Returns

BDXBUS Medical EquipmentUS Market
7D0%-4.8%-4.6%
1Y-3.3%-0.4%7.7%

Return vs Industry: BDXB underperformed the US Medical Equipment industry which returned -0.4% over the past year.

Return vs Market: BDXB underperformed the US Market which returned 7.7% over the past year.

Price Volatility

Is BDXB's price volatile compared to industry and market?
BDXB volatility
BDXB Average Weekly Movement2.5%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.6%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.4%

Stable Share Price: BDXB is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: BDXB's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
189775,000Tom Polenhttps://www.bd.com

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company’s BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers.

Becton Dickinson Fundamentals Summary


Earnings & Revenue

Key profitability statistics from the latest earnings report
BDXB income statement (TTM)
RevenueUS$20.25b
Cost of RevenueUS$10.67b
Gross ProfitUS$9.58b
ExpensesUS$7.57b
EarningsUS$2.00b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Feb 03, 2022

Earnings per share (EPS)7.02
Gross Margin47.29%
Net Profit Margin9.89%
Debt/Equity Ratio74.4%

How did BDXB perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

48%

Payout Ratio

Does BDXB pay a reliable dividends?

See BDXB dividend history and benchmarks
When do you need to buy BDXB by to receive an upcoming dividend?
Becton Dickinson dividend dates
Ex Dividend DateFeb 14 2022
Dividend Pay DateMar 01 2022
Days until Ex dividend24 days
Days until Dividend pay date39 days

Does BDXB pay a reliable dividends?

See BDXB dividend history and benchmarks

Valuation

Is Becton Dickinson undervalued compared to its fair value and its price relative to the market?

33.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: BDXB ($54.69) is trading below our estimate of fair value ($81.82)

Significantly Below Fair Value: BDXB is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: BDXB is good value based on its PE Ratio (37.6x) compared to the US Medical Equipment industry average (46.1x).

PE vs Market: BDXB is poor value based on its PE Ratio (37.6x) compared to the US market (16.9x).


Price to Earnings Growth Ratio

PEG Ratio: BDXB is poor value based on its PEG Ratio (2.7x)


Price to Book Ratio

PB vs Industry: BDXB is good value based on its PB Ratio (3.2x) compared to the US Medical Equipment industry average (3.5x).


Future Growth

How is Becton Dickinson forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?

14.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BDXB's forecast earnings growth (14.1% per year) is above the savings rate (2%).

Earnings vs Market: BDXB's earnings (14.1% per year) are forecast to grow faster than the US market (13.1% per year).

High Growth Earnings: BDXB's earnings are forecast to grow, but not significantly.

Revenue vs Market: BDXB's revenue (3.2% per year) is forecast to grow slower than the US market (9.3% per year).

High Growth Revenue: BDXB's revenue (3.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BDXB's Return on Equity is forecast to be low in 3 years time (15%).


Past Performance

How has Becton Dickinson performed over the past 5 years?

16.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BDXB has a large one-off loss of $693.0M impacting its September 30 2021 financial results.

Growing Profit Margin: BDXB's current net profit margins (9.9%) are higher than last year (4.5%).


Past Earnings Growth Analysis

Earnings Trend: BDXB's earnings have grown by 16.1% per year over the past 5 years.

Accelerating Growth: BDXB's earnings growth over the past year (161%) exceeds its 5-year average (16.1% per year).

Earnings vs Industry: BDXB earnings growth over the past year (161%) exceeded the Medical Equipment industry 51.2%.


Return on Equity

High ROE: BDXB's Return on Equity (8.8%) is considered low.


Financial Health

How is Becton Dickinson's financial position?


Financial Position Analysis

Short Term Liabilities: BDXB's short term assets ($8.8B) exceed its short term liabilities ($6.6B).

Long Term Liabilities: BDXB's short term assets ($8.8B) do not cover its long term liabilities ($23.6B).


Debt to Equity History and Analysis

Debt Level: BDXB's net debt to equity ratio (64.7%) is considered high.

Reducing Debt: BDXB's debt to equity ratio has reduced from 151.5% to 74.4% over the past 5 years.

Debt Coverage: BDXB's debt is well covered by operating cash flow (26.4%).

Interest Coverage: BDXB's interest payments on its debt are well covered by EBIT (7.3x coverage).


Balance Sheet


Dividend

What is Becton Dickinson current dividend yield, its reliability and sustainability?

1.32%

Current Dividend Yield


Upcoming Dividend Payment

TodayJan 21 2022Ex Dividend DateFeb 14 2022Dividend Pay DateMar 01 202215 days from Ex DividendBuy in the next 24 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: BDXB's dividend (1.32%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.34%).

High Dividend: BDXB's dividend (1.32%) is low compared to the top 25% of dividend payers in the US market (3.49%).


Stability and Growth of Payments

Stable Dividend: BDXB's dividends per share have been stable in the past 10 years.

Growing Dividend: BDXB's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (48%), BDXB's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: BDXB's dividends in 3 years are forecast to be well covered by earnings (29.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Tom Polen (48 yo)

4.75yrs

Tenure

US$14,189,333

Compensation

Mr. Thomas E. Polen, Jr., also known as Tom, serves as Chief Executive Officer and Director at Becton, Dickinson and Company since January 28, 2020. Mr. Polen has been President of Becton, Dickinson and Co...


CEO Compensation Analysis

Compensation vs Market: Tom's total compensation ($USD14.19M) is about average for companies of similar size in the US market ($USD11.31M).

Compensation vs Earnings: Tom's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: BDXB's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

Experienced Board: BDXB's board of directors are considered experienced (8.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Becton, Dickinson and Company's employee growth, exchange listings and data sources


Key Information

  • Name: Becton, Dickinson and Company
  • Ticker: BDXB
  • Exchange: NYSE
  • Founded: 1897
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$75.243b
  • Shares outstanding: 285.04m
  • Website: https://www.bd.com

Number of Employees


Location

  • Becton, Dickinson and Company
  • 1 Becton Drive
  • Franklin Lakes
  • New Jersey
  • 07417-1880
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/20 23:51
End of Day Share Price2022/01/20 00:00
Earnings2021/09/30
Annual Earnings2021/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.